Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This Traditional Chinese Medicine (TCM) herbal compound is a combination of *Polygonum cuspidatum* (Huzhang), *Taraxacum* (Dandelion), *Sophora flavescens* (Kushen), and *Phellodendron* (Huangbai). Developed by the Shanghai Yueyang Integrated Traditional Chinese Medicine and Western Medicine Hospital, it is formulated based on the TCM principle of "heat-clearing and dampness-promoting" (清热利湿). The compound is primarily investigated as an adjunctive postoperative analgesic therapy for patients undergoing hemorrhoid surgery. Its therapeutic effects are attributed to the anti-inflammatory and analgesic properties of its active constituents, such as resveratrol from Huzhang, matrine and oxymatrine from Sophora, and berberine from Phellodendron, which help reduce local edema and pain at the surgical site.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huzhang + dandelion + sophora flavescens + phellodendron.